To test the hypothesis that the presence of FMISO volumes might predict for biochemical relapse, we conducted an exploratory analysis and found more biochemical relapse in the FMISO-positive patients than in the FMISO-negative patients, but this difference did not reach statistical significance.
← all excerpts
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using <sup>18</sup>F-fluoromisonidazole PET/CT: a pilot study.
1
—
—